Cite

HARVARD Citation

    Marshall, D. et al. (2020). Adherence to human epidermal growth factor receptor-2 testing and adjuvant trastuzumab treatment guidelines in Ontario. Journal of oncology pharmacy practice. pp. 379-385. [Online]. 
  
Back to record